Portfolio (Quarterly)
Guide ↗
China Universal Asset Management Co., Ltd.
· CIK 0001906594| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 301 | — | KINIKSA PHARMACEUTICALS INTE | — | 7,359.0 | $304K | 0.02% | -261.0 | -3.4% | $41.25 | — |
| 302 | HTHT | H WORLD GROUP LTD-ADR | Consumer Cyclical | 6,398.0 | $301K | 0.02% | -4K | -37.3% | $47.05 | -10.8% |
| 303 | LEGN | LEGEND BIOTECH CORP-ADR | Healthcare | 13,720.0 | $298K | 0.02% | -1K | -7.0% | $21.74 | -12.4% |
| 304 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 14,163.0 | $298K | 0.02% | -936.0 | -6.2% | $21.01 | -14.2% |
| 305 | VCEL | VERICEL CORP | Healthcare | 8,241.0 | $297K | 0.02% | -604.0 | -6.8% | $36.01 | +9.8% |
| 306 | HROW | HARROW INC | Healthcare | 6,035.0 | $296K | 0.02% | -451.0 | -7.0% | $49.00 | -32.9% |
| 307 | — | DYNAVAX TECHNOLOGIES CORP | — | 19,134.0 | $294K | 0.02% | -1K | -6.9% | $15.38 | — |
| 308 | GMAB | GENMAB A/S -SP ADR | Healthcare | 9,525.0 | $293K | 0.02% | +2K | +29.6% | $30.80 | +13.9% |
| 309 | HLT | HILTON WORLDWIDE HOLDINGS IN | Consumer Cyclical | 1,021.0 | $293K | 0.02% | — | — | $287.25 | +9.0% |
| 310 | GLUE | MONTE ROSA THERAPEUTICS INC | Healthcare | 18,611.0 | $292K | 0.02% | -12K | -39.6% | $15.68 | -24.5% |
| 311 | PHVS | PHARVARIS NV | Healthcare | 10,438.0 | $290K | 0.02% | +7K | +247.9% | $27.75 | +18.9% |
| 312 | ANIP | ANI PHARMACEUTICALS INC | Healthcare | 3,660.0 | $289K | 0.02% | -142.0 | -3.7% | $78.94 | -6.1% |
| 313 | SEPN | SEPTERNA INC | Healthcare | 10,296.0 | $287K | 0.02% | NEW | — | $27.88 | +36.1% |
| 314 | OMER | OMEROS CORP | Healthcare | 16,553.0 | $284K | 0.02% | -5K | -24.5% | $17.18 | +18.5% |
| 315 | MNKD | MANNKIND CORP | Healthcare | 50,037.0 | $284K | 0.02% | -4K | -7.0% | $5.67 | -42.2% |
| 316 | DGX | QUEST DIAGNOSTICS INC | Healthcare | 1,600.0 | $278K | 0.02% | NEW | — | $173.53 | +36.1% |
| 317 | BCRX | BIOCRYST PHARMACEUTICALS INC | Healthcare | 34,308.0 | $268K | 0.02% | -2K | -6.8% | $7.80 | +9.7% |
| 318 | ALVO | ALVOTECH SA | Healthcare | 51,006.0 | $262K | 0.02% | -4K | -7.0% | $5.13 | +14.1% |
| 319 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 20,895.0 | $262K | 0.02% | -451.0 | -2.1% | $12.52 | +15.7% |
| 320 | FTRE | FORTREA HOLDINGS INC | Healthcare | 15,057.0 | $260K | 0.02% | -859.0 | -5.4% | $17.25 | +14.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Technology
40.3%
Healthcare
21.6%
Communication Services
10.8%
Financial Services
10.7%
Consumer Cyclical
10.3%
Consumer Defensive
2.8%
Industrials
2.0%
Utilities
0.6%
Basic Materials
0.5%
Energy
0.4%